National policies for xenotransplantation in the USA

Eda T Bloom

doi:10.1111/j.1399-3089.2007.00396.x

National policies for xenotransplantation in the USA

Xenotransplantation. 2007 Jul;14(4):345-6. doi: 10.1111/j.1399-3089.2007.00396.x.

Author

Eda T Bloom¹

Affiliation

¹ Gene Transfer and Immunogenicity Branch, Division of Cellular and Gene Therapies, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA. eda.bloom@fda.hhs.gov

PMID: 17669177
DOI: 10.1111/j.1399-3089.2007.00396.x

Abstract

An overview of xenotransplantation regulatory policies in the USA was presented at the Satellite Symposium, ''Xenotransplantation--Current Standards for Clinical Trials,'' held in conjunction with the World Transplant Congress, Boston, MA, USA 2006. This article summarizes that overview.

MeSH terms

Animals
Clinical Trials as Topic / standards
Guidelines as Topic*
Humans
Public Policy
Transplantation, Heterologous / legislation & jurisprudence*
Transplantation, Heterologous / standards*
United States
United States Food and Drug Administration* / legislation & jurisprudence
United States Food and Drug Administration* / standards